Ftse Mib
33.607,14
0,00%
DAX
19.033,64
-2,14%
S&P 500
5.983,99
-0,29%
NASDAQ
19.281,40
-0,09%
Bitcoin
86.510,67
-1,61%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Coya Therapeutics Inc (COYA) Coya Therapeutics Inc (COYA) Notizie

Coya Therapeutics Inc

COYA
7,20
-0,13 (-1,77%)
13 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/11/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:02EDGAR2Form 8-K - Current report
06/11/202414:00BWCoya Therapeutics Provides a Corporate Update and Reports..
05/11/202423:02EDGAR2Form 8-K - Current report
01/11/202413:15BWCoya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes..
31/10/202421:42EDGAR2Form 8-K - Current report
29/10/202413:00EDGAR2Form 8-K - Current report
29/10/202411:30BWCoya Therapeutics Announces Positive Results of a..
28/10/202422:00EDGAR2Form D - Notice of Exempt Offering of Securities
28/10/202413:00BWCoya Therapeutics Announces Conference Call to Report..
23/10/202422:05BWCoya Therapeutics Announces Closing of $10.0 Million Private..
22/10/202415:08EDGAR2Form 8-K - Current report
22/10/202415:00BWCoya Therapeutics Announces $10.0 Million Private Placement
08/10/202415:15BWCoya Therapeutics Chairman and CEO Howard Berman Selected..
24/9/202414:15BWCoya Therapeutics to Participate in Fireside Chat at the..
16/9/202414:15BWCoya Therapeutics Announces Subcutaneously Administered COYA..
03/9/202414:15BWCoya Therapeutics to Present at Upcoming Healthcare..
20/8/202421:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/8/202415:10EDGAR2Form 8-K - Current report
19/8/202415:00BWCoya Therapeutics Promotes Arun Swaminathan Ph.D. to Chief..
12/8/202414:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:04EDGAR2Form 8-K - Current report
12/8/202414:00BWCoya Therapeutics Provides a Corporate Update and Reports..
02/8/202414:15BWCoya Therapeutics Announces that Results from a Double-Blind..
31/7/202414:15BWCoya Therapeutics Expands Pipeline and Intellectual Property..
15/7/202412:10EDGAR2Form 8-K - Current report
20/6/202414:15BWCoya Therapeutics Expands Sponsored Research Collaboration..
14/6/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
11/6/202414:15BWCoya Therapeutics Announces Publication of ALS Study in..
06/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202414:00EDGAR2Form 8-K - Current report
03/6/202414:15BWCoya Therapeutics Announces Acceptance of Peer-Reviewed..
28/5/202414:15BWCoya Therapeutics Announces Inclusion in the MSCI USA Micro..
22/5/202414:15BWCoya Therapeutics Announces the Completion of a Controlled..
20/5/202423:00EDGAR2Form 8-K - Current report
20/5/202414:15BWCoya Therapeutics Announces $5 Million Strategic Investment..
09/5/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:10BWCoya Therapeutics Provides a Corporate Update and Reports..
08/5/202423:21EDGAR2Form 8-K - Current report
26/4/202414:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
22/4/202414:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
18/4/202414:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
08/4/202414:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
19/3/202413:15BWCoya Therapeutics Provides a Corporate Update and Reports..
12/3/202414:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
12/3/202413:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
Apertura: 7,31 Min: 6,97 Max: 7,31
Chiusura: 7,33

La tua Cronologia

NASDAQ
COYA
Coya Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network